Loading...
Last submissions
-
Aleix Tarrés-Solé, Federica Battistini, Joachim Gerhold, Olivier Piétrement, Belén Martínez-García, et al.. Structural analysis of the Candida albicans mitochondrial DNA maintenance factor Gcf1p reveals a dynamic DNA-bridging mechanism. Nucleic Acids Research, 2023, ⟨10.1093/nar/gkad397⟩. ⟨hal-04120278⟩
-
-
-
-
Francois Bertucci, Vincent Niziers, Alexandre de Nonneville, Pascal Finetti, Léna Mescam, et al.. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. Journal for Immunotherapy of Cancer, 2022, 10 (1), pp.e003687. ⟨10.1136/jitc-2021-003687⟩. ⟨hal-03583256⟩
-
David Boulate, Marine Fidelle, Caroline Caramella, Justin Issard, Olivier Planche, et al.. Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol. BMJ Open, 2022, 12 (12), ⟨10.1136/bmjopen-2022-067191⟩. ⟨hal-03926501⟩
-
-
Carla E Cano, María José Sandí, Tewfik Hamidi, Ezequiel L Calvo, Olivier Turrini, et al.. Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer.. EMBO Molecular Medicine, 2012, 4 (9), pp.964-79. ⟨10.1002/emmm.201201255⟩. ⟨hal-01016917⟩
-
Alexandre Bourdiol, Vincent Legros, Fanny Vardon-Bounes, Thomas Rimmele, Paul Abraham, et al.. Prevalence and risk factors of significant persistent pain symptoms after critical care illness: a prospective multicentric study. Critical Care, 2023, 27 (1), pp.199. ⟨10.1186/s13054-023-04491-w⟩. ⟨hal-04141716⟩
-
-
Fabiola Giudici, Barbara Pistilli, Inês Vaz-Luis, Maryam Karimi, Suzette Delaloge, et al.. Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer. British Journal of Cancer, 2023, ⟨10.1038/s41416-023-02420-w⟩. ⟨hal-04231469⟩
-
-
-
-
-
Sandrine Caputo, Lisa Golmard, Mélanie Léone, Francesca Damiola, Marine Guillaud-Bataille, et al.. Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach. American Journal of Human Genetics, 2021, 108 (10), pp.1907-1923. ⟨10.1016/j.ajhg.2021.09.003⟩. ⟨hal-03375857⟩
-
Raphael J. Morscher, Caroline Brard, Pablo Berlanga, Lynley V. Marshall, Nicolas André, et al.. First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial. European Journal of Cancer, 2021, 157, pp.268-277. ⟨10.1016/j.ejca.2021.08.010⟩. ⟨hal-03487880⟩
-
Florent Milliet, Alexandre Bozec, Renaud Schiappa, Julien Viotti, Anouchka Modesto, et al.. Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study. Oral Oncology, 2021, 122, pp.105503. ⟨10.1016/j.oraloncology.2021.105503⟩. ⟨hal-03627840⟩
-
Louise Benoit, Jonathan Zerbib, Meriem Koual, Huyen-Thu Nguyen-Xuan, Nicolas Delanoy, et al.. What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?. Gynecologic Oncology, 2021, 162 (3), pp.667-673. ⟨10.1016/j.ygyno.2021.06.025⟩. ⟨hal-03907039⟩
-
Albane Gareton, Arnault Tauziède-Espariat, Volodia Dangouloff-Ros, Alexandre Roux, Raphaël Saffroy, et al.. The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population. Acta Neuropathologica, 2019, ⟨10.1007/s00401-019-02088-8⟩. ⟨hal-02441067⟩